BRIEF published on 08/05/2024 at 19:00, 3 months 15 days ago Molten Ventures Plc: Major Shareholding Update Voting Rights Institutional Investors Shareholding BlackRock Molten Ventures
PRESS RELEASE published on 08/05/2024 at 18:55, 3 months 15 days ago Molten Ventures Plc: HOL-Holding(s) in Company Molten Ventures Plc reports change in voting rights. BlackRock, Inc. now holds 13.37% voting rights through shares and financial instruments Voting Rights Molten Ventures Plc Notification BlackRock Inc. GB00BY7QYJ50
BRIEF published on 08/05/2024 at 08:05, 3 months 16 days ago Molten Ventures Plc Announces Share Buyback Share Capital Voting Rights Share Repurchase Numis Securities Molten Ventures
PRESS RELEASE published on 08/05/2024 at 08:00, 3 months 16 days ago Molten Ventures Plc: POS-Transaction in Own Shares Molten Ventures Plc announces purchase of 85,000 Ordinary Shares as part of share repurchase program. Details of highest, lowest, and average prices disclosed Ordinary Shares Molten Ventures Plc Numis Securities Limited Stock Market Share Repurchase Program
BRIEF published on 08/02/2024 at 08:05, 3 months 19 days ago Molten Ventures Plc Announces Share Repurchase Details Share Repurchase Stock Market Numis Securities Molten Ventures Financial Regulations
PRESS RELEASE published on 08/02/2024 at 08:00, 3 months 19 days ago Molten Ventures Plc: POS-Transaction in Own Shares Molten Ventures Plc announces transaction in own shares with detailed purchase information. Company's issued share capital and voting rights updated post-purchase Voting Rights Shares Molten Ventures Plc Purchase Transaction
BRIEF published on 08/01/2024 at 19:12, 3 months 19 days ago BlackRock Increases Stake in Molten Ventures Plc Voting Rights Investment Shareholding BlackRock Molten Ventures
PRESS RELEASE published on 08/01/2024 at 19:07, 3 months 19 days ago Molten Ventures Plc: HOL-Holding(s) in Company* BlackRock, Inc. discloses holding in Molten Ventures Plc, crossing a threshold of 13.36% voting rights on 31-Jul-2024 Voting Rights Molten Ventures Plc Major Holdings Notification BlackRock, Inc.
BRIEF published on 08/01/2024 at 08:05, 3 months 20 days ago Molten Ventures Plc Declares Total Voting Rights Share Capital Transparency Total Voting Rights Molten Ventures Regulatory Update
BRIEF published on 08/01/2024 at 08:05, 3 months 20 days ago Molten Ventures Plc Executes Share Repurchase Program Share Repurchase Stock Market Numis Securities Molten Ventures Shareholder Notification
Published on 11/21/2024 at 17:35, 38 minutes ago 1upHealth Ranked Number 43 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500(TM)
Published on 11/21/2024 at 17:30, 43 minutes ago SimpliGov and Proof Partner to Offer Online Notarization
Published on 11/21/2024 at 16:30, 1 hour 43 minutes ago The Rise of DINKs: Dual-Income Couples Without Kids Redefine Financial Priorities in America
Published on 11/21/2024 at 16:01, 2 hours 12 minutes ago Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License
Published on 11/21/2024 at 16:00, 2 hours 13 minutes ago Financial Independence Group Announces Exclusive Partnership With Power of Zero and Tax-Free Retirement Expert David McKnight
Published on 11/21/2024 at 17:51, 21 minutes ago LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 21 minutes ago 2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.
Published on 11/21/2024 at 15:41, 2 hours 31 minutes ago Edison issues report on Murray Income Trust (MUT)
Published on 11/21/2024 at 06:58, 11 hours 15 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 22 hours 53 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 10 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
